Impact Biomedical (IBO) Minority Interest (2022 - 2026)
Impact Biomedical's (IBO) quarterly Minority Interest came in at $3.2 million in Q1 2026, up 9.44% YoY from $3.0 million in Q1 2025, and little changed on a QoQ basis from $3.2 million in Q4 2025.
Impact Biomedical (IBO) Minority Interest (2022 - 2026) Analysis & Trends
Impact Biomedical (IBO) has 5 years of Minority Interest data on file, last reported at $3.2 million in Q1 2026.
- Quarterly Minority Interest rose 9.44% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 9.44% YoY) and the FY2025 annual result came in at $3.2 million, up 8.93% from the prior year.
- Minority Interest was little changed at $3.2 million in Q1 2026, from $3.2 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $3.2 million in Q1 2026 to a low of $3.0 million in Q3 2025.
- A 5-year average of $3.1 million and a median of $3.0 million in 2024 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2024 — Minority Interest slipped 2.34% — and 2026, when it gained 9.44%.
- Tracing IBO's Minority Interest over 5 years: stood at $3.1 million in 2022, then dropped by 2.28% to $3.0 million in 2023, then decreased by 2.04% to $3.0 million in 2024, then gained by 8.93% to $3.2 million in 2025, then rose by 0.09% to $3.2 million in 2026.
- The last three Minority Interest figures came in at $3.2 million (Q1 2026), $3.2 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Impact Biomedical | 49.54 Mn | 49.53 Mn | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.25 Mn |
| Mar 31, 2026 | 3.25 Mn |
| Dec 31, 2025 | 3.24 Mn |
| Sep 30, 2025 | 2.96 Mn |
| Jun 30, 2025 | 2.96 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 2.98 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.01 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 3.04 Mn |
| Sep 30, 2023 | 3.07 Mn |
| Jun 30, 2023 | 3.08 Mn |
| Dec 31, 2022 | 3.11 Mn |